Published by Iain Gilbert on 15th June 2026
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its cancer drug Truqap, used with abiraterone and prednisone, has been approved in the US as the first targeted treatment for a form of advanced prostate cancer driven by a fault in the PTEN gene.
URL: http://www.digitallook.com/dl/news/story/36000137/...